2nd Gen Fluoroquinolone
Use: Soft tissue infections; anthrax prophylaxis; TB, M kansasii, M. fortuitum, systemic infections/UTI's; lower resp. tract infections, infections of skin, bones and joints;
Mechanism: inhibition of DNA gyrase of the susceptible bacteria
Spectrum: Broad spectrum Gram + and -; notably pseudomonas aeruginosa, MRSA; E. coli, klebsiella pneumoniae, enterobacter cholerae, proteus mirabilis, P. vulgaris, pseudomonas aeruginosa, staphylococcus aureus, staphylococcus epidermidis, streptococcus marcescens, providencia rettgeri, morganella morganii, salmonella sp, shigella, campylobacter, yersinia sp, vibrio
PHK: Mg Interfere with absorption; poorly penetrates CSF
Adverse rxns: GI distrubances; all quinolones Increase QT interval; transient elevations of serum transaminase, LDH, alkaline phosphatases etc; tendon rupture
Resistance: altered target
Other Drugs: Levofloxacin (Levaquin®) Ofloxacin (Floxin®)
|